Tapewire

Nasdaq · USD

GEHC

GE HealthCare Technologies Inc.

Export transactions ↓
Tapewire entity
1711
SEC CIK
0001932393
Parsed reports
254

Last 12 months

Inside the activity.

8 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202620
May 202660
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 14, 2026 Filed Sep 16, 2026 22:01 UTC
Grogan William KChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 31,877 $0.00 Strike: $64.25 $0.00
Disclosure

SEC source: 0001694002-26-000011 · wk-form4_1789596117.xml · derivative · entry 3

Grogan William K · CIK 0001694002 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,877

Underlying: Common Stock, par value $0.01 per share · 31,877 shares

Expires 2036-09-14

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Read SEC document
September 14, 2026 Filed Sep 16, 2026 22:01 UTC
Grogan William KChief Financial Officer
GrantCommon Stock, par value $0.01 per share 12,840 $0.00 $0.00
Disclosure

SEC source: 0001694002-26-000011 · wk-form4_1789596117.xml · nonDerivative · entry 2

Grogan William K · CIK 0001694002 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,096

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

Read SEC document
September 14, 2026 Filed Sep 16, 2026 22:01 UTC
Grogan William KChief Financial Officer
GrantCommon Stock, par value $0.01 per share 62,256 $0.00 $0.00
Disclosure

SEC source: 0001694002-26-000011 · wk-form4_1789596117.xml · nonDerivative · entry 1

Grogan William K · CIK 0001694002 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,256

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on September 14, 2027, and 50% will vest on September 14, 2028.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:46 UTC Tax withholdingCommon Stock, par value $0.01 per share 798 $70.56 $56,306.88
Disclosure

SEC source: 0002027284-26-000013 · wk-form4_1788554780.xml · nonDerivative · entry 1

Rackliffe Philip · CIK 0002027284 · CEO, AIS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,533

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:45 UTC Tax withholdingCommon Stock, par value $0.01 per share 718 $70.56 $50,662.08
Disclosure

SEC source: 0001951605-26-000008 · wk-form4_1788554702.xml · nonDerivative · entry 1

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,026

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:44 UTC
Newcomb George A.Chief Accounting Officer
Tax withholdingCommon Stock, par value $0.01 per share 112 $70.56 $7,902.72
Disclosure

SEC source: 0001952158-26-000008 · wk-form4_1788554645.xml · nonDerivative · entry 1

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,515

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:43 UTC
Kass-Hout TahaChief Technology Officer
Tax withholdingCommon Stock, par value $0.01 per share 1,502 $70.56 $105,981.12
Disclosure

SEC source: 0001960652-26-000011 · wk-form4_1788554579.xml · nonDerivative · entry 1

Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,467

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:42 UTC
Jimenez Frank RGC & Corporate Secretary
Tax withholdingCommon Stock, par value $0.01 per share 1,480 $70.56 $104,428.80
Disclosure

SEC source: 0001465175-26-000025 · wk-form4_1788554541.xml · nonDerivative · entry 1

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,321

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:41 UTC
Holton Adam YChief People Officer
Tax withholdingCommon Stock, par value $0.01 per share 673 $70.56 $47,486.88
Disclosure

SEC source: 0001657919-26-000009 · wk-form4_1788554494.xml · nonDerivative · entry 1

Holton Adam Y · CIK 0001657919 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,533

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:40 UTC
Estrampes CatherineChief Commer. & Growth Officer
Tax withholdingCommon Stock, par value $0.01 per share 508 $70.56 $35,844.48
Disclosure

SEC source: 0002131383-26-000006 · wk-form4_1788554438.xml · nonDerivative · entry 1

Estrampes Catherine · CIK 0002131383 · Chief Commer. & Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,573

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:39 UTC
Arduini Peter JDirector · President and CEO
Tax withholdingCommon Stock, par value $0.01 per share 6,303 $70.56 $444,739.68
Disclosure

SEC source: 0001323134-26-000022 · wk-form4_1788554361.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 241,606

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:18 UTC
Kass-Hout TahaChief Technology Officer
Tax withholdingCommon Stock, par value $0.01 per share 1,296 $71.23 $92,314.08
Disclosure

SEC source: 0001960652-26-000009 · wk-form4_1788466702.xml · nonDerivative · entry 2

Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,969

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:18 UTC
Kass-Hout TahaChief Technology Officer
Tax withholdingCommon Stock, par value $0.01 per share 1,644 $71.23 $117,102.12
Disclosure

SEC source: 0001960652-26-000009 · wk-form4_1788466702.xml · nonDerivative · entry 1

Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,265

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:18 UTC Tax withholdingCommon Stock, par value $0.01 per share 340 $71.23 $24,218.20
Disclosure

SEC source: 0002027284-26-000011 · wk-form4_1788466724.xml · nonDerivative · entry 3

Rackliffe Philip · CIK 0002027284 · CEO, AIS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,331

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:18 UTC Tax withholdingCommon Stock, par value $0.01 per share 226 $71.23 $16,097.98
Disclosure

SEC source: 0002027284-26-000011 · wk-form4_1788466724.xml · nonDerivative · entry 2

Rackliffe Philip · CIK 0002027284 · CEO, AIS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,671

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:18 UTC Tax withholdingCommon Stock, par value $0.01 per share 290 $71.23 $20,656.70
Disclosure

SEC source: 0002027284-26-000011 · wk-form4_1788466724.xml · nonDerivative · entry 1

Rackliffe Philip · CIK 0002027284 · CEO, AIS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,897

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:17 UTC
Jimenez Frank RGC & Corporate Secretary
Tax withholdingCommon Stock, par value $0.01 per share 1,380 $71.23 $98,297.40
Disclosure

SEC source: 0001465175-26-000023 · wk-form4_1788466662.xml · nonDerivative · entry 2

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,801

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:17 UTC
Jimenez Frank RGC & Corporate Secretary
Tax withholdingCommon Stock, par value $0.01 per share 1,751 $71.23 $124,723.73
Disclosure

SEC source: 0001465175-26-000023 · wk-form4_1788466662.xml · nonDerivative · entry 1

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,181

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:17 UTC
Holton Adam YChief People Officer
Tax withholdingCommon Stock, par value $0.01 per share 659 $71.23 $46,940.57
Disclosure

SEC source: 0001657919-26-000007 · wk-form4_1788466636.xml · nonDerivative · entry 1

Holton Adam Y · CIK 0001657919 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,206

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:16 UTC
Bankes JeannetteCEO, Patient Care Solutions
Tax withholdingCommon Stock, par value $0.01 per share 1,064 $71.23 $75,788.72
Disclosure

SEC source: 0001920839-26-000007 · wk-form4_1788466599.xml · nonDerivative · entry 1

Bankes Jeannette · CIK 0001920839 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,293

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:16 UTC
Arduini Peter JDirector · President and CEO
Tax withholdingCommon Stock, par value $0.01 per share 5,472 $71.23 $389,770.56
Disclosure

SEC source: 0001323134-26-000020 · wk-form4_1788466573.xml · nonDerivative · entry 2

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,909

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:16 UTC
Arduini Peter JDirector · President and CEO
Tax withholdingCommon Stock, par value $0.01 per share 6,043 $71.23 $430,442.89
Disclosure

SEC source: 0001323134-26-000020 · wk-form4_1788466573.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,381

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
August 15, 2026 Filed Aug 18, 2026 20:14 UTC
Holton Adam YChief People Officer
Tax withholdingCommon Stock, par value $0.01 per share 1,360 $73.69 $100,218.40
Disclosure

SEC source: 0001657919-26-000004 · wk-form4_1787084055.xml · nonDerivative · entry 1

Holton Adam Y · CIK 0001657919 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,865

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
May 22, 2026 Filed May 26, 2026 22:44 UTC
Lobo KevinDirector
PurchaseCommon Stock, par value $0.01 per share 10,000 $64.18 $641,800.00
Disclosure

SEC source: 0001519419-26-000011 · wk-form4_1779835492.xml · nonDerivative · entry 1

Lobo Kevin · CIK 0001519419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,363

Read SEC document
May 15, 2026 Filed May 19, 2026 20:05 UTC GrantCommon Stock, par value $0.01 per share 16,458 $0.00 $0.00
Disclosure

SEC source: 0002027284-26-000008 · wk-form4_1779221108.xml · nonDerivative · entry 1

Rackliffe Philip · CIK 0002027284 · CEO, AIS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,187

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on May 15, 2028, and 50% will vest on May 15, 2029.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:04 UTC
Bankes JeannetteCEO, Patient Care Solutions
Tax withholdingCommon Stock, par value $0.01 per share 5,535 $62.67 $346,878.45
Disclosure

SEC source: 0001920839-26-000004 · wk-form4_1779221065.xml · nonDerivative · entry 1

Bankes Jeannette · CIK 0001920839 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,357

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
May 12, 2026 Filed May 13, 2026 20:19 UTC PurchaseCommon Stock, par value $0.01 per share 1,618 $62.03 $100,364.54
Disclosure

SEC source: 0001468966-26-000004 · wk-form4_1778703550.xml · nonDerivative · entry 1

Hochman Rodney F · CIK 0001468966 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trust

Disclosed balance after: 1,618

Read SEC document
May 08, 2026 Filed May 12, 2026 00:16 UTC PurchaseCommon Stock, par value $0.01 per share 1,000 $63.01 $63,006.30
Disclosure

SEC source: 0001940538-26-000002 · wk-form4_1778544964.xml · nonDerivative · entry 2

Yang Watkin Phoebe L. · CIK 0001940538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,702

F3 · price: The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
May 07, 2026 Filed May 12, 2026 00:08 UTC GrantCommon Stock, par value $0.01 per share 2,282 $0.00 $0.00
Disclosure

SEC source: 0001684059-26-000002 · wk-form4_1778544519.xml · nonDerivative · entry 2

Madden Anne T · CIK 0001684059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,479

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.

Read SEC document
May 07, 2026 Filed May 12, 2026 00:08 UTC GrantCommon Stock, par value $0.01 per share 3,586 $0.00 $0.00
Disclosure

SEC source: 0001684059-26-000002 · wk-form4_1778544519.xml · nonDerivative · entry 1

Madden Anne T · CIK 0001684059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,197

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan").

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 07, 2026 Filed May 12, 2026 00:12 UTC GrantCommon Stock, par value $0.01 per share 2,689 $0.00 $0.00
Disclosure

SEC source: 0001468966-26-000002 · wk-form4_1778544776.xml · nonDerivative · entry 2

Hochman Rodney F · CIK 0001468966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,886

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.

Read SEC document
May 07, 2026 Filed May 12, 2026 00:12 UTC GrantCommon Stock, par value $0.01 per share 3,586 $0.00 $0.00
Disclosure

SEC source: 0001468966-26-000002 · wk-form4_1778544776.xml · nonDerivative · entry 1

Hochman Rodney F · CIK 0001468966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,197

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan").

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 07, 2026 Filed May 12, 2026 00:07 UTC GrantCommon Stock, par value $0.01 per share 3,586 $0.00 $0.00
Disclosure

SEC source: 0001352578-26-000006 · wk-form4_1778544462.xml · nonDerivative · entry 1

Stromberg William J · CIK 0001352578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,916

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 07, 2026 Filed May 12, 2026 00:14 UTC GrantCommon Stock, par value $0.01 per share 4,157 $0.00 $0.00
Disclosure

SEC source: 0001205247-26-000008 · wk-form4_1778544891.xml · nonDerivative · entry 2

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,442

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.

Read SEC document
May 07, 2026 Filed May 12, 2026 00:14 UTC GrantCommon Stock, par value $0.01 per share 3,586 $0.00 $0.00
Disclosure

SEC source: 0001205247-26-000008 · wk-form4_1778544891.xml · nonDerivative · entry 1

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,285

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan").

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 07, 2026 Filed May 12, 2026 00:12 UTC GrantCommon Stock, par value $0.01 per share 3,586 $0.00 $0.00
Disclosure

SEC source: 0001256992-26-000004 · wk-form4_1778544729.xml · nonDerivative · entry 1

LESJAK CATHERINE A · CIK 0001256992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,702

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 07, 2026 Filed May 12, 2026 00:10 UTC
Lobo KevinDirector
GrantCommon Stock, par value $0.01 per share 3,586 $0.00 $0.00
Disclosure

SEC source: 0001519419-26-000009 · wk-form4_1778544646.xml · nonDerivative · entry 1

Lobo Kevin · CIK 0001519419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,363

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 07, 2026 Filed May 12, 2026 00:16 UTC GrantCommon Stock, par value $0.01 per share 3,586 $0.00 $0.00
Disclosure

SEC source: 0001940538-26-000002 · wk-form4_1778544964.xml · nonDerivative · entry 1

Yang Watkin Phoebe L. · CIK 0001940538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,702

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 06, 2026 Filed May 7, 2026 20:09 UTC PurchaseCommon Stock, par value $0.01 per share 1,000 $61.69 $61,689.20
Disclosure

SEC source: 0001352578-26-000004 · wk-form4_1778184524.xml · nonDerivative · entry 1

Stromberg William J · CIK 0001352578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,330

Read SEC document
May 06, 2026 Filed May 7, 2026 20:14 UTC PurchaseCommon Stock, par value $0.01 per share 80,805 $61.88 $5,000,076.03
Disclosure

SEC source: 0001205247-26-000006 · wk-form4_1778184869.xml · nonDerivative · entry 1

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By holding company

Disclosed balance after: 151,207

F1 · price: The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $61.50 to $62.22, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
May 01, 2026 Filed May 1, 2026 15:38 UTC
SACCARO JAMESChief Financial Officer
PurchaseCommon Stock, par value $0.01 per share 3,310 $60.60 $200,585.01
Disclosure

SEC source: 0001593636-26-000008 · wk-form4_1777649933.xml · nonDerivative · entry 1

SACCARO JAMES · CIK 0001593636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,471

F1 · price: The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $60.59 to $60.60, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
April 30, 2026 Filed Apr 30, 2026 20:21 UTC
Jimenez Frank RGC & Corporate Secretary
PurchaseCommon Stock, par value $0.01 per share 1,750 $60.45 $105,787.50
Disclosure

SEC source: 0001465175-26-000015 · wk-form4_1777580461.xml · nonDerivative · entry 1

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,932

Read SEC document
April 30, 2026 Filed Apr 30, 2026 20:20 UTC
Arduini Peter JDirector · President and CEO
PurchaseCommon Stock, par value $0.01 per share 4,169 $59.93 $249,827.33
Disclosure

SEC source: 0001323134-26-000014 · wk-form4_1777580401.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,424

Read SEC document
March 13, 2026 Filed Mar 17, 2026 20:08 UTC
Lobo KevinDirector
GrantCommon Stock, par value $0.01 per share 777 $0.00 $0.00
Disclosure

SEC source: 0001519419-26-000006 · wk-form4_1773778094.xml · nonDerivative · entry 1

Lobo Kevin · CIK 0001519419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 777

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) March 13, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:24 UTC GrantEmployee Stock Option (right to buy) · Derivative 24,598 $0.00 Strike: $80.16 $0.00
Disclosure

SEC source: 0002027284-26-000006 · wk-form4_1772659448.xml · derivative · entry 2

Rackliffe Philip · CIK 0002027284 · CEO, AVS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,598

Underlying: Common Stock, par value $0.01 per share · 24,598 shares

Expires 2036-03-02

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:24 UTC GrantCommon Stock, par value $0.01 per share 9,356 $0.00 $0.00
Disclosure

SEC source: 0002027284-26-000006 · wk-form4_1772659448.xml · nonDerivative · entry 1

Rackliffe Philip · CIK 0002027284 · CEO, AVS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,729

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:27 UTC
Bankes JeannetteCEO, Patient Care Solutions
GrantEmployee Stock Option (right to buy) · Derivative 18,038 $0.00 Strike: $80.16 $0.00
Disclosure

SEC source: 0001920839-26-000002 · wk-form4_1772659635.xml · derivative · entry 2

Bankes Jeannette · CIK 0001920839 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,038

Underlying: Common Stock, par value $0.01 per share · 18,038 shares

Expires 2036-03-02

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:27 UTC
Bankes JeannetteCEO, Patient Care Solutions
GrantCommon Stock, par value $0.01 per share 6,861 $0.00 $0.00
Disclosure

SEC source: 0001920839-26-000002 · wk-form4_1772659635.xml · nonDerivative · entry 1

Bankes Jeannette · CIK 0001920839 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,892

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:26 UTC
Jimenez Frank RGC & Corporate Secretary
GrantEmployee Stock Option (right to buy) · Derivative 28,697 $0.00 Strike: $80.16 $0.00
Disclosure

SEC source: 0001465175-26-000008 · wk-form4_1772659615.xml · derivative · entry 2

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,697

Underlying: Common Stock, par value $0.01 per share · 28,697 shares

Expires 2036-03-02

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:26 UTC
Jimenez Frank RGC & Corporate Secretary
GrantCommon Stock, par value $0.01 per share 10,915 $0.00 $0.00
Disclosure

SEC source: 0001465175-26-000008 · wk-form4_1772659615.xml · nonDerivative · entry 1

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,182

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.